U.S. BIOCHIP PRODUCT AND SERVICES MARKET ANALYSIS

Market News

U.S. Biochip Product & Services Market: Key Developments

On May 18, 2023, Abbott Laboratories, an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, U.S., announced its Assert-IQ insertable cardiac monitor (ICM) biochip has received U.S. Food and Drug Administration (FDA) clearance, giving physicians a new option for diagnostic evaluation and long-term monitoring of people experiencing irregular heartbeats. This clearance builds on Abbott's portfolio of connected health devices that can better help doctors manage and treat their patients remotely.

On June 6, 2023, Agilent Technologies Inc., a medical company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories, announced the release of the enhanced xCELLigence RTCA Software Pro Version 2.8, an integrated software package for running and analyzing real-time cell analysis data. This improved version enables Agilent xCELLigence Real-Time Cell Analysis (RTCA) systems in GMP-regulated facilities.

In December 2022, Pulmostics Limited is developing a diagnostic system that detects early breast cancer based on Breath Analysis in the U.S., announced that in conjunction with the prestigious CHRISTUS Muguerza Alta Especialidad Hospital and the CHRISTUS CEI Clinical Research Center in Monterrey, Nuevo León, México, has begun a clinical trial to validate the use of a Pulmostics Limited breath to detect breast cancer in women.

On March 09, 2023, Agilent Technologies Inc., a medical company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories, announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell.

In March 2022, U.S. startup Nutcracker Therapeutics raises US$ 167 million for the advancement of its mRNA biochip-based manufacturing platform. In May 2021, TU Wien, which is a major university in Austria developed a biochip that could be used to produce tissue beads in the desired size and supply them with drugs or nutrients.